• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Weekly, May 16, 2016

The CenterWatch Weekly, May 16, 2016

May 16, 2016
CenterWatch Staff

New consortium supports clinical research in struggling Puerto Rico

 A newly established consortium aims to enhance and promote clinical research and drug development in Puerto Rico. It is hoped that the consortium will combat declin­ing clinical trials in the region to benefit patients, the Puerto Rican economy and global science. Established in April, the Puerto Rico Consortium for Clinical Investigation (PRCCI) is a nonprofit government trust of academic and private research sites. The goal of PRCCI is to support best practices, improve and standardize quality, share knowledge and promote the success of clinical trials on the island.

 

Can machine learning technology aid in patient recruitment?

Researchers at Cincinnati Children’s Hospital have come up with a novel ap­proach to the ever-challenging problem of patient recruitment for clinical trials: a math­ematical algorithm that enables computers to predict whether a patient will accept an invitation to enroll in a trial. A type of machine learning technology, the algorithm essentially teaches computers to make predictions about patient behavior by analyzing and interpreting patient demographic and socio­economic data, while factoring in characteristics of the trial itself, such as length. The technique has been widely used for a variety of clinical tasks, such as identifying signs and symptoms of specific diseases.

 

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing